Immunovant, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Immunovant, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2019 to Q2 2024.
  • Immunovant, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2024 was -$182K, a 304% decline year-over-year.
  • Immunovant, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$360K, a 82.7% decline from 2022.
  • Immunovant, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$197K, a 22.4% increase from 2021.
  • Immunovant, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$254K, a 21% decline from 2020.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$182K -$137K -304% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q2 2023 -$45K -$3K -7.14% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q2 2022 -$42K -$24K -133% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q2 2021 -$18K +$29K +61.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q2 2020 -$47K -$47K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.